> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Kenvue Sales Rise 3.2% For A Fourth Straight Quarter, But No Guidance Or Call Ahead Of Kimberly-Clark Deal
- URL: https://www.bullished.co/kenvue-sales-rise-3-2-for-a-fourth-straight-quarter-but-no-guidance-or-call-ahead-of-b260e925/
- Published: 2026-10-30T11:07:32.000Z
- Updated: 2026-10-30T11:07:32.000Z
- Description: The Tylenol maker's operating margin widened to 18.2% and nine-month free cash flow reached $1.6 billion.
- Author: Matteo Parrino
- Tags: SEC Filings, KVUE, Industry: Consumer Staples

[Kenvue](https://www.bullished.co/tag/kvue/), the consumer health company behind Tylenol and Band-Aid, said third-quarter [net sales rose 3.2%](https://www.sec.gov/Archives/edgar/data/0001944048/000194404826000167/q326earningspressrelease.htm?ref=bullished.co) and operating margin widened, in results released Friday. Because of its pending transaction with Kimberly-Clark, it is giving no forward-looking guidance and holding no quarterly conference call.

## Volume and pricing both contributed

Organic sales, which exclude currency swings and acquisitions or divestitures, rose 2.9%, with volume up 1.6% and pricing and mix up 1.3%. Currency added 0.3 percentage points. It was the fourth consecutive quarter of net and organic sales growth, the company said in an [8-K](https://www.sec.gov/Archives/edgar/data/0001944048/000194404826000167/kvue-20261030.htm?ref=bullished.co) furnishing the results for the quarter ended September 27, 2026.

Self Care led, with organic sales up 5.4%. The company cited a rebound in Asia Pacific after last year's trade inventory depletion, a Motrin outperformance as flu cases rose, and low double-digit growth in smoking cessation led by Nicorette. In the U.S., Tylenol gained market share despite lower seasonal incidence and category softness.

Essential Health organic sales rose 2.5%, helped by Johnson's Baby, Stayfree, o.b. and Band-Aid wound care. Skin Health and Beauty organic sales fell 0.5%, with volume down 1.7%, on U.S. distribution losses, promotion timing and retailer negotiations in Europe. Hair Care grew at a low double-digit rate, led by Rogaine.

## Margins widen, tax rate climbs

Operating margin [reached 18.2%](https://www.businesswire.com/news/home/20261030384426/en/Kenvue-Reports-Third-Quarter-2026-Results?ref=bullished.co), from 16.7% a year earlier. Adjusted operating margin was 21.9%, against 21.5%. Gross margin was 59.5%, from 59.1%, helped by supply chain savings, U.S. tariff refunds and pricing.

Diluted earnings per share rose 5% [to $0.22](https://www.businesswire.com/news/home/20261030384426/en/Kenvue-Reports-Third-Quarter-2026-Results?ref=bullished.co), and adjusted diluted earnings per share rose 4% to $0.29\. The effective tax rate rose to 29.4% from 24.3%, mainly because fewer favorable one-time tax adjustments, partly offset by tax law changes.

For the first nine months, free cash flow rose to $1.6 billion from $1.0 billion, as operating cash flow reached $1.9 billion from $1.3 billion. Total debt was $8.2 billion at quarter end, versus $8.5 billion at December 28, 2025.

## A deal that replaces the forecast

Kenvue sells consumer health products, including over-the-counter medicines, skin care and personal care under brands such as Tylenol, Neutrogena, Aveeno and Listerine, in more than 165 countries. Net sales were $15.1 billion in fiscal 2025, according to its annual report.

CEO Kirk Perry said the company is nearing completion of its "value-creating combination with Kimberly-Clark." Kenvue also cited savings from a 2026 restructuring initiative approved by the board on February 17, 2026, which is expected to carry about $250 million in pre-tax charges in fiscal 2026.

Kenvue said it will post the results release at investors.kenvue.com in place of a call.

Learn

- [Item 2.02: results of operations →](https://www.bullished.co/learn/8-k-items-explained/#item-202-results-of-operations)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — Kenvue Inc. (KVUE)](https://www.sec.gov/Archives/edgar/data/0001944048/000194404826000167/kvue-20261030.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit q326earningspressrelease.htm — Kenvue Inc. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001944048/000194404826000167/q326earningspressrelease.htm?ref=bullished.co) — SEC EDGAR
- [Kenvue Reports Third Quarter 2026 Results](https://www.businesswire.com/news/home/20261030384426/en/Kenvue-Reports-Third-Quarter-2026-Results?ref=bullished.co) — businesswire.com

### More on Kenvue

- [Kenvue Bondholders Back Stripping Covenants From All Seven Note Series, $7 Billion In Total](https://www.bullished.co/kenvue-bondholders-back-stripping-covenants-from-all-seven-note-series-7-billion-in-total-bc1147c3/)

[All Kenvue (KVUE) coverage →](https://www.bullished.co/tag/kvue/)